FDA NDC Directory · JSON-LD · Markdown

SAPHNELO

NDC 0310-3080 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameAnifrolumab-fnia
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryBiologic License Application · App BLA761451
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsANIFROLUMAB (120 mg/.8mL)
Marketing started20260424
Package count3

External sources

Source: openFDA. Public-domain (CC0).